Celebrex - Celecoxib capsules - Pfizer - COX-2 inhibitor approved for ankylosing spondylitis

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:296 / 296
页数:1
相关论文
共 50 条
  • [2] Celecoxib, a COX-2 specific inhibitor in ankylosing spondylitis (AS). A 6-week efficacy study.
    Dougados, M
    Behier, JM
    Jolchine, I
    Calin, A
    van der Heijde, D
    Olivieri, I
    Zeidler, H
    Herman, H
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S103 - S103
  • [3] Celecoxib: A COX-2 inhibitor
    Andrews, SA
    Wallace, CK
    Davis, RL
    AMERICAN JOURNAL OF MANAGED CARE, 1999, 5 (04): : 511 - 518
  • [4] Connection of COX-2 variants to ankylosing spondylitis susceptibility
    Liu, Hongyun
    Wang, Bin
    Zhang, Qiliang
    JOURNAL OF CELLULAR PHYSIOLOGY, 2023, 238 (10) : 2528 - 2532
  • [6] Clinical pharmacology of celecoxib, a COX-2 selective inhibitor
    Antoniou, Katerina
    Malamas, Michael
    Drosos, Alexandros A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (11) : 1719 - 1732
  • [7] COX-2 and its inhibitor Celecoxib in corneal neovascularization
    Dong, Yuan
    Zhang, Ming-Chang
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2008, 1 (01) : 13 - 17
  • [8] Discovery of the COX-2 selective inhibitor celecoxib.
    Talley, JJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U56 - U56
  • [9] Efficacy and safety of celecoxib, a specific COX-2 inhibitor, in osteoarthritis
    Geis, GS
    Hubbard, RC
    Woods, EM
    Yu, S
    Zhao, W
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (09) : S45 - S45
  • [10] Celecoxib: A COX-2 inhibitor for the treatment of osteoarthritis and rheumatoid arthritis
    Boyce, EG
    Breen, GA
    FORMULARY, 1999, 34 (05) : 405 - +